Clinical trial
Development and Validation of a Novel Functional Eye-Tracking Software Application for Neurological Disorders
NCT05212727 is registered in ClinicalTrials.gov with Innodem Neurosciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Development and Validation of a Novel Functional Eye-Tracking Software Application for Neurological Disorders
- Lead sponsor
- Innodem Neurosciences
- Phase
- Observational
- Overall status
- Terminated
- Start date
- April 15, 2022
- Completion date
- May 3, 2024
- Enrollment
- 300 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
neurological disorders